History

Neuréva is born from the wish of three scientists, who have been collaborating for ten years, to transfer their academic knowledge to the development of innovative therapies for CNS repair.

Neuréva’s know how is based on three decades of academic innovative research dedicated to the comprehension of the pathophysiological mechanisms that follow a central nervous system injury. CNS plasticity, relevant models of CNS pathologies and neuropharmacology are the three complementary approaches that are anchoring the project.

History at a glance

January 2008

Financial support of our leading R&D program by the French Agency for Innovation OSEO (0,9 M€)

December 2007

Transformation into a limited company with a capital of 126 K€

November 2007

First fundraising in November 2007: A new Associate and Shareholder, Mr Bruno FRANCOIS, joins Neuréva

June 2004

Neurévas’ project is awarded a National Grant for innovative consolidated projects by the Ministry of Research and Technology

April 2004

Incorporation of Neuréva as a limited liability company

                                     

July 2003

Neurévas’ project is awarded a prize in the national competition by the Ministry of Research and Technology in the category of innovative emerging projects.